biomedicina slovenica

re="Atherosclerosis" : 15

  1. Poredoš Pavel
    Markers of preclinical atherosclerosis and their clinical relevance
    2011 ►
  2. Lunder Mojca; Janić Miodrag; Habjan Sara; Šabovič Mišo
    Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males - a pilot study
    2011 ►
  3. Eržen B; Šabovič M; Šebeštjen M; Poredoš P; Keber I
    IL-6 correlates with endothelial dysfunction in young post-myocardial infarction patients
    2006 ►
  4. Šebeštjen M; Eržen B; Šabovič M; Poredoš P; Keber I
    Role of endothelial function and inflammation in patient with cardiovascular risk factors, with and without a history of myocardial infarction
    2006 ►
  5. Rozman D; Kuzman D; Černe M; Fon-Tacer K; Režen T; Čegovnik U; Ačimovič J; Urleb U
    Genetic and biochemical evaluation of the poloxamer P407-induced chronic hyperlipidemia in the mouse
    2005 ►
  6. Poredoš Pavel
    Involvement of endothelial dysfunction in atherogenesis
    2004 ►
  7. Meisel SR; Xu XP; Edgington TS; Dimayuga P; Kaul S; Lee S; Fishbein MC; Čerček B; Shah PK
    Differentiation of adherent human monocytes into macrophages markedly enhances tissue factor protein expression and procoagulant activity
    2002 ►
  8. Čerček B; Yamashita M; Dimayuga P; Zhu J; Fishbein MC; Kaul S; Shah PK; Nilsson J; Renstrom J
    Nuclear factor-kappaB activity and arterial response to balloon injury
    1997 ►
  9. Žegura Branka; Keber Irena; Šebeštjen Miran; Koenig Wolfgang
    Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis
    2003 ►
  10. Meroni Pier Luigi; Raschi Elena; Testoni Cinzia; Riboni Monica; Praprotnik Sonja; Schoenfeld Yehuda
    Functional heterogeneity of pathogenic anti-endothelial cell antibodies
    2001 ►
  11. Šebeštjen M; Žegura B; Keber I
    Cerivastatin improves flow-mediated dilatation more than fenofibrate in males with mixed hyperlipidemia
    2000 ►
  12. Žegura B; Šebeštjen M; Keber I; Borko E
    No difference in improvement of flow mediated dilation after oral or transdermal estradiol substitution after surgical induced menopause
    2000 ►
  13. Rubinstein A; Marais AD; Szostak WB; Colquhoun D; Keber I; Werba JP; Bertolami M; Stolero D; Tal S
    Efficacy and safety of cerivastatin 0.8 mg versus pravastatin 40 mg for treatment of dyslipidaemia
    2000 ►
  14. Kanc-Hanžel K; Vreča I; Kocijančič A
    Plasma magnesium and zinc in type I and type II diabetic patients
    1995 ►
  15. Turk J; Kenda M; Koželj M; Zalokar V; Jokovič Ž
    Clinical value of apolipoproteins A1 and B determinations
    1989 ►


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics